Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer: A Single-arm, One Center Study

NCT07090031 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT07090031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer: A Single-arm, One Center Study
Lead sponsor
Qingdao Central Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 1, 2025
Completion date
May 1, 2028
Enrollment
49 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

efs, pcr rate